We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Altered Peripheral B-Lymphocyte Subsets in Type 1 Diabetes and Latent Autoimmune Diabetes in Adults.
- Authors
Chao Deng; Yufei Xiang; Tingting Tan; Ren, Zhihui; Chuqing Cao; Gan Huang; Li Wen; Zhiguang Zhou; Deng, Chao; Xiang, Yufei; Tan, Tingting; Cao, Chuqing; Huang, Gan; Wen, Li; Zhou, Zhiguang
- Abstract
<bold>Objective: </bold>B lymphocytes play an important role in the immunopathogenesis of autoimmune diabetes. We hypothesized that the altered B-cell subset phenotype is associated with autoimmune diabetes.<bold>Research Design and Methods: </bold>Patients with type 1 diabetes (T1D) (n = 81), latent autoimmune diabetes in adults (LADA) (n = 82), or type 2 diabetes (T2D) (n = 95) and healthy control subjects (n = 218) with normal glucose tolerance (NGT) were recruited. We determined the percentage of circulating B-lymphocyte subsets, including CD19(+)CD23(-)CD21(+) (marginal zone B [MZB]), CD19(+)CD23(+)CD21(-) (follicular B [FoB]), and CD19(+)CD5(+)CD1d(hi) (interleukin-10-producing regulatory B [B10]) cells by flow cytometry.<bold>Results: </bold>Patients with T1D or LADA had increased percentages of MZB cells and decreased percentages of FoB cells compared with healthy control subjects with NGT and patients with T2D. Moreover, patients with T1D showed the lowest frequency of B10 cells compared with patients with LADA or T2D, whereas healthy control subjects expressed the highest frequency of B10 cells. Of note, the frequency of MZB cells was negatively associated and the frequency of FoB cells was positively associated with fasting C-peptide (FCP). The frequency of B10 cells was positively correlated with FCP and negatively correlated with hemoglobin A(1c).<bold>Conclusions: </bold>The data show that patients with T1D or LADA express an altered frequency of B-cell subsets, which is associated with islet function and glycemia. These findings suggest that B lymphocytes may be involved in loss of self-tolerance and β-cell destruction and could be used as a biomarker and potential target for immunological intervention.
- Subjects
TYPE 1 diabetes; AUTOIMMUNE diseases; LYMPHOCYTES; PEPTIDES; IMMUNOLOGY; B cells; COMPARATIVE studies; RESEARCH methodology; MEDICAL cooperation; TYPE 2 diabetes; RESEARCH; EVALUATION research
- Publication
Diabetes Care, 2016, Vol 39, Issue 3, p434
- ISSN
0149-5992
- Publication type
journal article
- DOI
10.2337/dc15-1765